

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.44441843 |
| 2 | proteasome assembly (GO:0043248) | 4.71545885 |
| 3 | cullin deneddylation (GO:0010388) | 4.45748389 |
| 4 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.35341534 |
| 5 | protein deneddylation (GO:0000338) | 4.27927206 |
| 6 | chaperone-mediated protein transport (GO:0072321) | 4.20863943 |
| 7 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.12733769 |
| 8 | termination of RNA polymerase III transcription (GO:0006386) | 4.12733769 |
| 9 | purine nucleobase biosynthetic process (GO:0009113) | 4.12144471 |
| 10 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.07774793 |
| 11 | nucleobase biosynthetic process (GO:0046112) | 4.04237006 |
| 12 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.03980579 |
| 13 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.00928206 |
| 14 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.96412818 |
| 15 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.95388213 |
| 16 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.93283884 |
| 17 | negative regulation of ligase activity (GO:0051352) | 3.93283884 |
| 18 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.86570749 |
| 19 | respiratory electron transport chain (GO:0022904) | 3.84489829 |
| 20 | peptidyl-histidine modification (GO:0018202) | 3.81280715 |
| 21 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.81054837 |
| 22 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.79936529 |
| 23 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.79936529 |
| 24 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.78914837 |
| 25 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.78914837 |
| 26 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.78914837 |
| 27 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.78464675 |
| 28 | 7-methylguanosine mRNA capping (GO:0006370) | 3.78296121 |
| 29 | electron transport chain (GO:0022900) | 3.77510757 |
| 30 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.76814570 |
| 31 | protein maturation by protein folding (GO:0022417) | 3.72195921 |
| 32 | RNA capping (GO:0036260) | 3.70928143 |
| 33 | 7-methylguanosine RNA capping (GO:0009452) | 3.70928143 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.70275140 |
| 35 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.68422447 |
| 36 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.68422447 |
| 37 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.66880037 |
| 38 | DNA strand elongation (GO:0022616) | 3.65102284 |
| 39 | DNA replication checkpoint (GO:0000076) | 3.64238461 |
| 40 | maturation of 5.8S rRNA (GO:0000460) | 3.58209723 |
| 41 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.54259548 |
| 42 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.54133625 |
| 43 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.54133625 |
| 44 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.53944661 |
| 45 | ribosomal small subunit assembly (GO:0000028) | 3.53720200 |
| 46 | ribosomal small subunit biogenesis (GO:0042274) | 3.47950683 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.46481687 |
| 48 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.44741435 |
| 49 | protein targeting to mitochondrion (GO:0006626) | 3.43843822 |
| 50 | ribosome biogenesis (GO:0042254) | 3.43395962 |
| 51 | viral mRNA export from host cell nucleus (GO:0046784) | 3.41394189 |
| 52 | formation of translation preinitiation complex (GO:0001731) | 3.41084919 |
| 53 | establishment of protein localization to mitochondrion (GO:0072655) | 3.39111301 |
| 54 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.36439002 |
| 55 | pseudouridine synthesis (GO:0001522) | 3.36394188 |
| 56 | DNA replication initiation (GO:0006270) | 3.32373731 |
| 57 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.32069118 |
| 58 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.30068514 |
| 59 | spliceosomal snRNP assembly (GO:0000387) | 3.29712122 |
| 60 | positive regulation of ligase activity (GO:0051351) | 3.29253459 |
| 61 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.28497342 |
| 62 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.28497342 |
| 63 | NADH dehydrogenase complex assembly (GO:0010257) | 3.28497342 |
| 64 | metallo-sulfur cluster assembly (GO:0031163) | 3.26480900 |
| 65 | iron-sulfur cluster assembly (GO:0016226) | 3.26480900 |
| 66 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.24986462 |
| 67 | viral transcription (GO:0019083) | 3.22648293 |
| 68 | translation (GO:0006412) | 3.21847235 |
| 69 | cotranslational protein targeting to membrane (GO:0006613) | 3.21268663 |
| 70 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.21183533 |
| 71 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.20433287 |
| 72 | proline biosynthetic process (GO:0006561) | 3.19231984 |
| 73 | protein targeting to ER (GO:0045047) | 3.17991285 |
| 74 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 3.17010188 |
| 75 | GDP-mannose metabolic process (GO:0019673) | 3.16076206 |
| 76 | cell cycle G1/S phase transition (GO:0044843) | 3.15399919 |
| 77 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.15399919 |
| 78 | establishment of viral latency (GO:0019043) | 3.15340035 |
| 79 | GMP metabolic process (GO:0046037) | 3.15084387 |
| 80 | protein complex biogenesis (GO:0070271) | 3.14293603 |
| 81 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.12992547 |
| 82 | protein localization to endoplasmic reticulum (GO:0070972) | 3.12646969 |
| 83 | rRNA modification (GO:0000154) | 3.11969929 |
| 84 | protein localization to mitochondrion (GO:0070585) | 3.10735766 |
| 85 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.08197245 |
| 86 | respiratory chain complex IV assembly (GO:0008535) | 3.08123373 |
| 87 | positive regulation of mitochondrial fission (GO:0090141) | 3.08105802 |
| 88 | base-excision repair, AP site formation (GO:0006285) | 3.07811804 |
| 89 | GTP biosynthetic process (GO:0006183) | 3.07480896 |
| 90 | translational elongation (GO:0006414) | 3.06652523 |
| 91 | regulation of mitochondrial translation (GO:0070129) | 3.05562628 |
| 92 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.05102582 |
| 93 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.04686500 |
| 94 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.04245913 |
| 95 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.03811895 |
| 96 | ATP synthesis coupled proton transport (GO:0015986) | 3.03811895 |
| 97 | oxidative phosphorylation (GO:0006119) | 3.01966875 |
| 98 | amino acid salvage (GO:0043102) | 3.01393990 |
| 99 | L-methionine salvage (GO:0071267) | 3.01393990 |
| 100 | L-methionine biosynthetic process (GO:0071265) | 3.01393990 |
| 101 | regulation of cellular amine metabolic process (GO:0033238) | 3.01369156 |
| 102 | translational termination (GO:0006415) | 2.99034120 |
| 103 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.98053880 |
| 104 | ribosomal large subunit biogenesis (GO:0042273) | 2.96957428 |
| 105 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.95540345 |
| 106 | positive regulation of cell cycle arrest (GO:0071158) | 2.95231873 |
| 107 | ubiquinone biosynthetic process (GO:0006744) | 2.94820876 |
| 108 | telomere maintenance via recombination (GO:0000722) | 2.94791531 |
| 109 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.93955908 |
| 110 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.93779605 |
| 111 | regulation of ligase activity (GO:0051340) | 2.93425715 |
| 112 | DNA excision (GO:0044349) | 2.92187977 |
| 113 | nucleotide-excision repair, DNA damage removal (GO:0000718) | 2.92187977 |
| 114 | UTP biosynthetic process (GO:0006228) | 2.91036151 |
| 115 | de novo protein folding (GO:0006458) | 2.90726221 |
| 116 | inner mitochondrial membrane organization (GO:0007007) | 2.90369401 |
| 117 | histone H2A acetylation (GO:0043968) | 2.90349042 |
| 118 | cytochrome complex assembly (GO:0017004) | 2.89561905 |
| 119 | mitochondrial RNA metabolic process (GO:0000959) | 2.89555944 |
| 120 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.89417449 |
| 121 | de novo posttranslational protein folding (GO:0051084) | 2.87121651 |
| 122 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.86057025 |
| 123 | translational initiation (GO:0006413) | 2.85590082 |
| 124 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.85526038 |
| 125 | cellular component biogenesis (GO:0044085) | 2.85003163 |
| 126 | mitochondrial transport (GO:0006839) | 2.84532713 |
| 127 | rRNA processing (GO:0006364) | 2.83974283 |
| 128 | establishment of integrated proviral latency (GO:0075713) | 2.83555706 |
| 129 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.82885377 |
| 130 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.82885377 |
| 131 | maturation of SSU-rRNA (GO:0030490) | 2.82685267 |
| 132 | nuclear envelope reassembly (GO:0031468) | 2.82584833 |
| 133 | protein neddylation (GO:0045116) | 2.79955192 |
| 134 | protein-cofactor linkage (GO:0018065) | 2.77401319 |
| 135 | spliceosomal complex assembly (GO:0000245) | 2.74532812 |
| 136 | DNA damage response, detection of DNA damage (GO:0042769) | 2.73770577 |
| 137 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.73411612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.65350180 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.49009618 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.19353963 |
| 4 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.04735954 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.97375905 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.87571780 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.86342760 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.74357645 |
| 9 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.61743393 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.55499246 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.17410876 |
| 12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.97920647 |
| 13 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.89905310 |
| 14 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.84272322 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.78707410 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.75600553 |
| 17 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.74821062 |
| 18 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.72371792 |
| 19 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.69973010 |
| 20 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.50883223 |
| 21 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.50668739 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.50484683 |
| 23 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.38478329 |
| 24 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.27526459 |
| 25 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.26167463 |
| 26 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.25079885 |
| 27 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.22781673 |
| 28 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.16784786 |
| 29 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.15674576 |
| 30 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.09330336 |
| 31 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 2.09274403 |
| 32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.08884606 |
| 33 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05111759 |
| 34 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.95989934 |
| 35 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.94088294 |
| 36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.91282107 |
| 37 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.88756555 |
| 38 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.86490998 |
| 39 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.82859395 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80580664 |
| 41 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.76961415 |
| 42 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.75756508 |
| 43 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.75428474 |
| 44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.73730643 |
| 45 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.73416280 |
| 46 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.70390943 |
| 47 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.66397704 |
| 48 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.66272006 |
| 49 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.63240855 |
| 50 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.61566467 |
| 51 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55877127 |
| 52 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.54344674 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.49830204 |
| 54 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.45412569 |
| 55 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.44329197 |
| 56 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.38975788 |
| 57 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.37169524 |
| 58 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.34784232 |
| 59 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.32827698 |
| 60 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31588862 |
| 61 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.29338904 |
| 62 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.26792703 |
| 63 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.24051877 |
| 64 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.22697449 |
| 65 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.17009063 |
| 66 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14147274 |
| 67 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.13261239 |
| 68 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13230755 |
| 69 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13106119 |
| 70 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12156336 |
| 71 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.10576084 |
| 72 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.09133006 |
| 73 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.08836892 |
| 74 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.05403491 |
| 75 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.03666133 |
| 76 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02872857 |
| 77 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.02651406 |
| 78 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.02515019 |
| 79 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.01188256 |
| 80 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.01101318 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99781190 |
| 82 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98023133 |
| 83 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97623198 |
| 84 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.97329040 |
| 85 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.97170996 |
| 86 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.95933685 |
| 87 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.94330722 |
| 88 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.93068964 |
| 89 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.92759727 |
| 90 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.91887540 |
| 91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91311784 |
| 92 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.90765639 |
| 93 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.90515285 |
| 94 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.90182138 |
| 95 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.89787798 |
| 96 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.87808139 |
| 97 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.86677452 |
| 98 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.86353036 |
| 99 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.86041832 |
| 100 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.84975759 |
| 101 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.83174996 |
| 102 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.82909245 |
| 103 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.81999164 |
| 104 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.81650077 |
| 105 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.81561247 |
| 106 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.79943527 |
| 107 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.77490910 |
| 108 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.76740498 |
| 109 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.76160781 |
| 110 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.75689578 |
| 111 | MYC_22102868_ChIP-Seq_BL_Human | 0.75528126 |
| 112 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.74858167 |
| 113 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.73551756 |
| 114 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.73089888 |
| 115 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.72810564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.36406959 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.61016384 |
| 3 | MP0000372_irregular_coat_pigmentation | 3.16750847 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 3.14943430 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.08180207 |
| 6 | MP0003111_abnormal_nucleus_morphology | 2.96793661 |
| 7 | MP0008877_abnormal_DNA_methylation | 2.72155977 |
| 8 | MP0001529_abnormal_vocalization | 2.65375931 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 2.63076745 |
| 10 | MP0003077_abnormal_cell_cycle | 2.61387058 |
| 11 | MP0008058_abnormal_DNA_repair | 2.50804021 |
| 12 | MP0008057_abnormal_DNA_replication | 2.42037020 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.28334923 |
| 14 | MP0002736_abnormal_nociception_after | 2.26585761 |
| 15 | MP0002822_catalepsy | 2.09289180 |
| 16 | MP0000015_abnormal_ear_pigmentation | 2.08185190 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.06518455 |
| 18 | MP0008260_abnormal_autophagy | 1.97988406 |
| 19 | MP0009046_muscle_twitch | 1.92366177 |
| 20 | MP0003635_abnormal_synaptic_transmissio | 1.88169398 |
| 21 | MP0008932_abnormal_embryonic_tissue | 1.88015681 |
| 22 | MP0002234_abnormal_pharynx_morphology | 1.87969396 |
| 23 | MP0003718_maternal_effect | 1.79948465 |
| 24 | MP0001984_abnormal_olfaction | 1.79440396 |
| 25 | MP0004270_analgesia | 1.76814117 |
| 26 | MP0002938_white_spotting | 1.75356605 |
| 27 | MP0002735_abnormal_chemical_nociception | 1.75283043 |
| 28 | MP0001905_abnormal_dopamine_level | 1.72636227 |
| 29 | MP0004147_increased_porphyrin_level | 1.69490351 |
| 30 | MP0008995_early_reproductive_senescence | 1.68358801 |
| 31 | MP0009745_abnormal_behavioral_response | 1.67607939 |
| 32 | MP0002064_seizures | 1.67171926 |
| 33 | MP0002734_abnormal_mechanical_nocicepti | 1.65210628 |
| 34 | MP0003123_paternal_imprinting | 1.56346990 |
| 35 | MP0002063_abnormal_learning/memory/cond | 1.54951544 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.52965886 |
| 37 | MP0003786_premature_aging | 1.52476714 |
| 38 | MP0001188_hyperpigmentation | 1.51080180 |
| 39 | MP0002272_abnormal_nervous_system | 1.49132903 |
| 40 | MP0006276_abnormal_autonomic_nervous | 1.47037348 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.44358400 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.43353841 |
| 43 | MP0003787_abnormal_imprinting | 1.41657427 |
| 44 | MP0002572_abnormal_emotion/affect_behav | 1.41598497 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.39509662 |
| 46 | MP0003879_abnormal_hair_cell | 1.38782192 |
| 47 | MP0008007_abnormal_cellular_replicative | 1.33908511 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 1.32498588 |
| 49 | MP0006035_abnormal_mitochondrial_morpho | 1.31118558 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.28972432 |
| 51 | MP0002132_abnormal_respiratory_system | 1.28070030 |
| 52 | MP0004142_abnormal_muscle_tone | 1.26124330 |
| 53 | MP0005075_abnormal_melanosome_morpholog | 1.25622964 |
| 54 | MP0001730_embryonic_growth_arrest | 1.25550153 |
| 55 | MP0005423_abnormal_somatic_nervous | 1.18445092 |
| 56 | MP0002751_abnormal_autonomic_nervous | 1.17670017 |
| 57 | MP0000350_abnormal_cell_proliferation | 1.14024147 |
| 58 | MP0002398_abnormal_bone_marrow | 1.13780869 |
| 59 | MP0002090_abnormal_vision | 1.13448926 |
| 60 | MP0001970_abnormal_pain_threshold | 1.13420787 |
| 61 | MP0004811_abnormal_neuron_physiology | 1.12979362 |
| 62 | MP0001440_abnormal_grooming_behavior | 1.12833271 |
| 63 | MP0003121_genomic_imprinting | 1.12691230 |
| 64 | MP0005671_abnormal_response_to | 1.12565745 |
| 65 | MP0006072_abnormal_retinal_apoptosis | 1.12324396 |
| 66 | MP0006292_abnormal_olfactory_placode | 1.10764718 |
| 67 | MP0002067_abnormal_sensory_capabilities | 1.10435699 |
| 68 | MP0003136_yellow_coat_color | 1.09299753 |
| 69 | MP0000313_abnormal_cell_death | 1.06476829 |
| 70 | MP0002733_abnormal_thermal_nociception | 1.04541778 |
| 71 | MP0004924_abnormal_behavior | 1.04498789 |
| 72 | MP0005386_behavior/neurological_phenoty | 1.04498789 |
| 73 | MP0001986_abnormal_taste_sensitivity | 1.03651530 |
| 74 | MP0003763_abnormal_thymus_physiology | 1.02459415 |
| 75 | MP0003806_abnormal_nucleotide_metabolis | 1.01177350 |
| 76 | MP0005408_hypopigmentation | 0.98902265 |
| 77 | MP0002095_abnormal_skin_pigmentation | 0.98591018 |
| 78 | MP0003186_abnormal_redox_activity | 0.96726952 |
| 79 | MP0000689_abnormal_spleen_morphology | 0.95807670 |
| 80 | MP0005646_abnormal_pituitary_gland | 0.95369119 |
| 81 | MP0009379_abnormal_foot_pigmentation | 0.94104571 |
| 82 | MP0003122_maternal_imprinting | 0.92141719 |
| 83 | MP0008872_abnormal_physiological_respon | 0.92026697 |
| 84 | MP0000358_abnormal_cell_content/ | 0.91704003 |
| 85 | MP0002184_abnormal_innervation | 0.91621000 |
| 86 | MP0002722_abnormal_immune_system | 0.91404021 |
| 87 | MP0005394_taste/olfaction_phenotype | 0.91341514 |
| 88 | MP0005499_abnormal_olfactory_system | 0.91341514 |
| 89 | MP0000490_abnormal_crypts_of | 0.90904832 |
| 90 | MP0009697_abnormal_copulation | 0.90700442 |
| 91 | MP0002429_abnormal_blood_cell | 0.88391928 |
| 92 | MP0000566_synostosis | 0.88038482 |
| 93 | MP0008789_abnormal_olfactory_epithelium | 0.87907150 |
| 94 | MP0008961_abnormal_basal_metabolism | 0.87768458 |
| 95 | MP0001764_abnormal_homeostasis | 0.86884111 |
| 96 | MP0004742_abnormal_vestibular_system | 0.86060323 |
| 97 | MP0003329_amyloid_beta_deposits | 0.85849726 |
| 98 | MP0000703_abnormal_thymus_morphology | 0.85184052 |
| 99 | MP0002420_abnormal_adaptive_immunity | 0.85035675 |
| 100 | MP0002210_abnormal_sex_determination | 0.84793969 |
| 101 | MP0000716_abnormal_immune_system | 0.84567456 |
| 102 | MP0001819_abnormal_immune_cell | 0.84155859 |
| 103 | MP0002163_abnormal_gland_morphology | 0.83837326 |
| 104 | MP0002019_abnormal_tumor_incidence | 0.83599941 |
| 105 | MP0002177_abnormal_outer_ear | 0.83360875 |
| 106 | MP0002160_abnormal_reproductive_system | 0.83113501 |
| 107 | MP0001835_abnormal_antigen_presentation | 0.82575832 |
| 108 | MP0002653_abnormal_ependyma_morphology | 0.81142640 |
| 109 | MP0008873_increased_physiological_sensi | 0.80132033 |
| 110 | MP0001929_abnormal_gametogenesis | 0.79966503 |
| 111 | MP0005645_abnormal_hypothalamus_physiol | 0.79364798 |
| 112 | MP0005389_reproductive_system_phenotype | 0.78740151 |
| 113 | MP0002066_abnormal_motor_capabilities/c | 0.77768562 |
| 114 | MP0001919_abnormal_reproductive_system | 0.77749111 |
| 115 | MP0009785_altered_susceptibility_to | 0.77605605 |
| 116 | MP0002080_prenatal_lethality | 0.77381349 |
| 117 | MP0001346_abnormal_lacrimal_gland | 0.75850963 |
| 118 | MP0005000_abnormal_immune_tolerance | 0.75714434 |
| 119 | MP0001486_abnormal_startle_reflex | 0.75541976 |
| 120 | MP0002557_abnormal_social/conspecific_i | 0.75309818 |
| 121 | MP0004133_heterotaxia | 0.74176690 |
| 122 | MP0002102_abnormal_ear_morphology | 0.73985376 |
| 123 | MP0005410_abnormal_fertilization | 0.71858372 |
| 124 | MP0001727_abnormal_embryo_implantation | 0.71199711 |
| 125 | MP0001697_abnormal_embryo_size | 0.70883167 |
| 126 | MP0001293_anophthalmia | 0.70544843 |
| 127 | MP0010307_abnormal_tumor_latency | 0.70179233 |
| 128 | MP0000653_abnormal_sex_gland | 0.69751689 |
| 129 | MP0002161_abnormal_fertility/fecundity | 0.69499002 |
| 130 | MP0005501_abnormal_skin_physiology | 0.69481546 |
| 131 | MP0001145_abnormal_male_reproductive | 0.69452311 |
| 132 | MP0003698_abnormal_male_reproductive | 0.69385612 |
| 133 | MP0005332_abnormal_amino_acid | 0.69360995 |
| 134 | MP0000049_abnormal_middle_ear | 0.69226697 |
| 135 | MP0002075_abnormal_coat/hair_pigmentati | 0.65503416 |
| 136 | MP0005551_abnormal_eye_electrophysiolog | 0.64808041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebral hypomyelination (HP:0006808) | 4.45101761 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.00195722 |
| 3 | Birth length less than 3rd percentile (HP:0003561) | 3.96012197 |
| 4 | Mitochondrial inheritance (HP:0001427) | 3.85881699 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.78700855 |
| 6 | Hepatocellular necrosis (HP:0001404) | 3.65928044 |
| 7 | Abnormality of glycolysis (HP:0004366) | 3.64392447 |
| 8 | Increased serum pyruvate (HP:0003542) | 3.64392447 |
| 9 | Increased CSF lactate (HP:0002490) | 3.51564433 |
| 10 | Abnormal number of erythroid precursors (HP:0012131) | 3.37162066 |
| 11 | Cerebral edema (HP:0002181) | 3.34101836 |
| 12 | Progressive macrocephaly (HP:0004481) | 3.14218221 |
| 13 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.14145478 |
| 14 | Increased serum lactate (HP:0002151) | 3.08762687 |
| 15 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.05349096 |
| 16 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.05349096 |
| 17 | Breast hypoplasia (HP:0003187) | 2.98922552 |
| 18 | Acute encephalopathy (HP:0006846) | 2.95429721 |
| 19 | Abnormal hair whorl (HP:0010721) | 2.95343638 |
| 20 | Hypokinesia (HP:0002375) | 2.94317136 |
| 21 | Hepatic necrosis (HP:0002605) | 2.89540804 |
| 22 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.87462812 |
| 23 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.84706121 |
| 24 | 3-Methylglutaconic aciduria (HP:0003535) | 2.82141479 |
| 25 | Postnatal microcephaly (HP:0005484) | 2.82068778 |
| 26 | CNS hypomyelination (HP:0003429) | 2.78015269 |
| 27 | Increased hepatocellular lipid droplets (HP:0006565) | 2.76029804 |
| 28 | Ragged-red muscle fibers (HP:0003200) | 2.74159608 |
| 29 | Atonic seizures (HP:0010819) | 2.73910623 |
| 30 | Type I transferrin isoform profile (HP:0003642) | 2.72269062 |
| 31 | Aplastic anemia (HP:0001915) | 2.69752029 |
| 32 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.69718009 |
| 33 | Delusions (HP:0000746) | 2.63860133 |
| 34 | Degeneration of anterior horn cells (HP:0002398) | 2.59030454 |
| 35 | Abnormality of the anterior horn cell (HP:0006802) | 2.59030454 |
| 36 | Methylmalonic aciduria (HP:0012120) | 2.58956982 |
| 37 | Epileptic encephalopathy (HP:0200134) | 2.58200303 |
| 38 | Lactic acidosis (HP:0003128) | 2.54739575 |
| 39 | Poor suck (HP:0002033) | 2.53011384 |
| 40 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.52113174 |
| 41 | Agnosia (HP:0010524) | 2.51586531 |
| 42 | Focal motor seizures (HP:0011153) | 2.47833271 |
| 43 | Oral leukoplakia (HP:0002745) | 2.46116778 |
| 44 | Type 2 muscle fiber atrophy (HP:0003554) | 2.42968852 |
| 45 | Respiratory failure (HP:0002878) | 2.41193896 |
| 46 | Hyperglycinemia (HP:0002154) | 2.41174341 |
| 47 | Generalized aminoaciduria (HP:0002909) | 2.40888859 |
| 48 | Exercise intolerance (HP:0003546) | 2.40426489 |
| 49 | Abnormal gallbladder physiology (HP:0012438) | 2.40362642 |
| 50 | Cholecystitis (HP:0001082) | 2.40362642 |
| 51 | Increased muscle lipid content (HP:0009058) | 2.38794596 |
| 52 | Lipid accumulation in hepatocytes (HP:0006561) | 2.38210823 |
| 53 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.38193117 |
| 54 | Abnormality of alanine metabolism (HP:0010916) | 2.38193117 |
| 55 | Hyperalaninemia (HP:0003348) | 2.38193117 |
| 56 | Abnormality of the labia minora (HP:0012880) | 2.36061727 |
| 57 | Renal Fanconi syndrome (HP:0001994) | 2.34404724 |
| 58 | Abnormal protein glycosylation (HP:0012346) | 2.32850141 |
| 59 | Abnormal glycosylation (HP:0012345) | 2.32850141 |
| 60 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.32850141 |
| 61 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.32850141 |
| 62 | Neuroendocrine neoplasm (HP:0100634) | 2.32448963 |
| 63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.30629759 |
| 64 | Dicarboxylic aciduria (HP:0003215) | 2.30629759 |
| 65 | IgM deficiency (HP:0002850) | 2.28634087 |
| 66 | Tongue fasciculations (HP:0001308) | 2.27667945 |
| 67 | Entropion (HP:0000621) | 2.26403702 |
| 68 | Emotional lability (HP:0000712) | 2.25888217 |
| 69 | Lethargy (HP:0001254) | 2.24948313 |
| 70 | Unsteady gait (HP:0002317) | 2.22978168 |
| 71 | Muscle fiber atrophy (HP:0100295) | 2.22607288 |
| 72 | Methylmalonic acidemia (HP:0002912) | 2.22002514 |
| 73 | Exertional dyspnea (HP:0002875) | 2.21826888 |
| 74 | Reticulocytopenia (HP:0001896) | 2.21622316 |
| 75 | Retinal dysplasia (HP:0007973) | 2.20787519 |
| 76 | Leukodystrophy (HP:0002415) | 2.18636246 |
| 77 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.17307643 |
| 78 | Rough bone trabeculation (HP:0100670) | 2.17093474 |
| 79 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.16856981 |
| 80 | Abnormality of the preputium (HP:0100587) | 2.13613457 |
| 81 | Progressive muscle weakness (HP:0003323) | 2.11178229 |
| 82 | Myokymia (HP:0002411) | 2.10622883 |
| 83 | Patellar aplasia (HP:0006443) | 2.10388945 |
| 84 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.08996912 |
| 85 | Absent epiphyses (HP:0010577) | 2.08996912 |
| 86 | Bone marrow hypocellularity (HP:0005528) | 2.08898133 |
| 87 | CNS demyelination (HP:0007305) | 2.07088434 |
| 88 | Respiratory difficulties (HP:0002880) | 2.05712968 |
| 89 | Multiple enchondromatosis (HP:0005701) | 2.05413106 |
| 90 | Microretrognathia (HP:0000308) | 2.04575911 |
| 91 | B lymphocytopenia (HP:0010976) | 2.02710997 |
| 92 | Increased intramyocellular lipid droplets (HP:0012240) | 2.00057571 |
| 93 | Medulloblastoma (HP:0002885) | 1.98945383 |
| 94 | Severe visual impairment (HP:0001141) | 1.98658921 |
| 95 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.98106520 |
| 96 | Prominent metopic ridge (HP:0005487) | 1.97517184 |
| 97 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.95730594 |
| 98 | Death in infancy (HP:0001522) | 1.95356621 |
| 99 | Horseshoe kidney (HP:0000085) | 1.94741570 |
| 100 | Tubulointerstitial nephritis (HP:0001970) | 1.94129073 |
| 101 | Delayed CNS myelination (HP:0002188) | 1.94097918 |
| 102 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.93564574 |
| 103 | Pancytopenia (HP:0001876) | 1.91665873 |
| 104 | Microvesicular hepatic steatosis (HP:0001414) | 1.91638085 |
| 105 | Severe global developmental delay (HP:0011344) | 1.89537952 |
| 106 | Poikiloderma (HP:0001029) | 1.88224588 |
| 107 | Optic disc pallor (HP:0000543) | 1.88108882 |
| 108 | Medial flaring of the eyebrow (HP:0010747) | 1.87993378 |
| 109 | Cellular immunodeficiency (HP:0005374) | 1.85790011 |
| 110 | Pheochromocytoma (HP:0002666) | 1.85587497 |
| 111 | Abnormality of the metopic suture (HP:0005556) | 1.83606118 |
| 112 | Progressive microcephaly (HP:0000253) | 1.83224263 |
| 113 | Diminished movement (HP:0002374) | 1.82757683 |
| 114 | Premature graying of hair (HP:0002216) | 1.82093717 |
| 115 | Opisthotonus (HP:0002179) | 1.81950080 |
| 116 | Gliosis (HP:0002171) | 1.81066663 |
| 117 | Hyperventilation (HP:0002883) | 1.80915177 |
| 118 | Upper limb muscle weakness (HP:0003484) | 1.78054598 |
| 119 | Macrocytic anemia (HP:0001972) | 1.77487601 |
| 120 | Pallor (HP:0000980) | 1.76913561 |
| 121 | Severe combined immunodeficiency (HP:0004430) | 1.76177530 |
| 122 | Failure to thrive in infancy (HP:0001531) | 1.75873643 |
| 123 | Shoulder girdle muscle weakness (HP:0003547) | 1.75257630 |
| 124 | Carpal bone hypoplasia (HP:0001498) | 1.75063362 |
| 125 | Esotropia (HP:0000565) | 1.74535110 |
| 126 | Gait imbalance (HP:0002141) | 1.74528541 |
| 127 | Spastic paraparesis (HP:0002313) | 1.72923896 |
| 128 | Nephrogenic diabetes insipidus (HP:0009806) | 1.72847129 |
| 129 | Brushfield spots (HP:0001088) | 1.72616198 |
| 130 | Muscular hypotonia of the trunk (HP:0008936) | 1.71768475 |
| 131 | Muscle fibrillation (HP:0010546) | 1.71398617 |
| 132 | Choreoathetosis (HP:0001266) | 1.71320819 |
| 133 | Abnormality of the ileum (HP:0001549) | 1.70965635 |
| 134 | Delayed myelination (HP:0012448) | 1.70898739 |
| 135 | Congenital primary aphakia (HP:0007707) | 1.69840876 |
| 136 | Meckel diverticulum (HP:0002245) | 1.69267655 |
| 137 | Protruding tongue (HP:0010808) | 1.66116447 |
| 138 | Cleft eyelid (HP:0000625) | 1.66044774 |
| 139 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.65493645 |
| 140 | Colon cancer (HP:0003003) | 1.63319168 |
| 141 | Premature ovarian failure (HP:0008209) | 1.61772402 |
| 142 | Abnormality of B cell number (HP:0010975) | 1.61431660 |
| 143 | X-linked dominant inheritance (HP:0001423) | 1.61304291 |
| 144 | Ependymoma (HP:0002888) | 1.57387666 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.59968350 |
| 2 | VRK2 | 4.30499331 |
| 3 | CASK | 3.59032882 |
| 4 | CDK19 | 3.56319523 |
| 5 | MAP3K12 | 3.42397222 |
| 6 | STK16 | 3.07640418 |
| 7 | BCKDK | 2.90700522 |
| 8 | CCNB1 | 2.85666896 |
| 9 | TESK2 | 2.80671221 |
| 10 | EIF2AK1 | 2.75699771 |
| 11 | TSSK6 | 2.68743776 |
| 12 | DAPK1 | 2.35618122 |
| 13 | WEE1 | 2.30865207 |
| 14 | CDC7 | 2.14005608 |
| 15 | VRK1 | 1.83585410 |
| 16 | MAP4K2 | 1.78867432 |
| 17 | EIF2AK3 | 1.78803730 |
| 18 | SIK3 | 1.70750370 |
| 19 | DAPK2 | 1.57619652 |
| 20 | AKT3 | 1.50753206 |
| 21 | BRAF | 1.45722691 |
| 22 | TRIM28 | 1.42627492 |
| 23 | SRPK1 | 1.40180448 |
| 24 | TLK1 | 1.35746168 |
| 25 | NME2 | 1.33784683 |
| 26 | NEK1 | 1.29154206 |
| 27 | NUAK1 | 1.29020889 |
| 28 | MARK1 | 1.23428542 |
| 29 | LIMK1 | 1.22553628 |
| 30 | IRAK4 | 1.22094635 |
| 31 | SCYL2 | 1.20216305 |
| 32 | PLK4 | 1.19952990 |
| 33 | CSNK1G2 | 1.19334003 |
| 34 | BRSK1 | 1.18287599 |
| 35 | PIM2 | 1.17785059 |
| 36 | MAP2K7 | 1.17636871 |
| 37 | ARAF | 1.16569813 |
| 38 | OXSR1 | 1.13734467 |
| 39 | PRPF4B | 1.13133522 |
| 40 | TESK1 | 1.12229448 |
| 41 | DYRK3 | 1.10534343 |
| 42 | MINK1 | 1.08238101 |
| 43 | PLK3 | 1.06851913 |
| 44 | CSNK1A1L | 1.05441664 |
| 45 | AURKA | 1.05246644 |
| 46 | EPHA4 | 1.03378361 |
| 47 | NME1 | 1.03363864 |
| 48 | RPS6KA4 | 1.01234127 |
| 49 | PLK2 | 1.00861130 |
| 50 | PDK2 | 1.00560697 |
| 51 | RPS6KA5 | 0.98761725 |
| 52 | EPHA2 | 0.98588660 |
| 53 | DYRK2 | 0.97871664 |
| 54 | PAK6 | 0.97039387 |
| 55 | PLK1 | 0.97013873 |
| 56 | BCR | 0.93227241 |
| 57 | ACVR1B | 0.92781020 |
| 58 | PASK | 0.92294186 |
| 59 | ABL2 | 0.89922286 |
| 60 | PHKG1 | 0.89381662 |
| 61 | PHKG2 | 0.89381662 |
| 62 | BLK | 0.87966342 |
| 63 | MAPK13 | 0.86229517 |
| 64 | CDK18 | 0.86078016 |
| 65 | CSNK1G1 | 0.83701630 |
| 66 | TNIK | 0.82419059 |
| 67 | MAP4K1 | 0.82163826 |
| 68 | MAP3K11 | 0.79080101 |
| 69 | RAF1 | 0.79070706 |
| 70 | BRSK2 | 0.77512123 |
| 71 | CDK7 | 0.76736148 |
| 72 | DAPK3 | 0.76277850 |
| 73 | AKT2 | 0.75672797 |
| 74 | CDK15 | 0.75075623 |
| 75 | MAPKAPK3 | 0.74640168 |
| 76 | TAOK3 | 0.72099459 |
| 77 | CLK1 | 0.71449934 |
| 78 | CDK11A | 0.71199221 |
| 79 | CDK14 | 0.69790318 |
| 80 | ATR | 0.68375544 |
| 81 | MKNK2 | 0.67727708 |
| 82 | RIPK4 | 0.67678336 |
| 83 | CDK8 | 0.66920040 |
| 84 | MKNK1 | 0.66549132 |
| 85 | SYK | 0.66222782 |
| 86 | YES1 | 0.64751366 |
| 87 | NTRK3 | 0.63634759 |
| 88 | MST4 | 0.60795831 |
| 89 | SMG1 | 0.60565392 |
| 90 | IRAK3 | 0.60488635 |
| 91 | CHEK1 | 0.60305945 |
| 92 | KSR1 | 0.59342736 |
| 93 | AURKB | 0.58623666 |
| 94 | MYLK | 0.56733362 |
| 95 | FES | 0.56339217 |
| 96 | TXK | 0.55496481 |
| 97 | ADRBK2 | 0.54763174 |
| 98 | PRKCG | 0.52671524 |
| 99 | ILK | 0.52579814 |
| 100 | KDR | 0.52186194 |
| 101 | UHMK1 | 0.51917235 |
| 102 | CAMKK2 | 0.50218679 |
| 103 | PAK1 | 0.49625401 |
| 104 | GRK6 | 0.49372798 |
| 105 | MAP3K5 | 0.48971269 |
| 106 | TAOK2 | 0.47899334 |
| 107 | ZAK | 0.47406123 |
| 108 | CAMK2G | 0.47092831 |
| 109 | CDK2 | 0.45962081 |
| 110 | CSNK2A1 | 0.45823711 |
| 111 | PNCK | 0.45513964 |
| 112 | CSNK2A2 | 0.45497305 |
| 113 | STK4 | 0.43396399 |
| 114 | CSNK1E | 0.42954810 |
| 115 | LMTK2 | 0.41869978 |
| 116 | MUSK | 0.41005899 |
| 117 | ATM | 0.40846996 |
| 118 | TTK | 0.40496068 |
| 119 | CHEK2 | 0.39935734 |
| 120 | PRKCI | 0.39826102 |
| 121 | LRRK2 | 0.39624160 |
| 122 | PKN1 | 0.38099266 |
| 123 | CDK5 | 0.37846853 |
| 124 | PDK4 | 0.37626280 |
| 125 | PDK3 | 0.37626280 |
| 126 | RPS6KB2 | 0.37546171 |
| 127 | PAK4 | 0.36849884 |
| 128 | DYRK1B | 0.36545906 |
| 129 | ALK | 0.35528793 |
| 130 | PRKD3 | 0.35293938 |
| 131 | ZAP70 | 0.35193747 |
| 132 | BMPR1B | 0.34038831 |
| 133 | NEK2 | 0.33517602 |
| 134 | PBK | 0.32831153 |
| 135 | CAMK2B | 0.32508342 |
| 136 | CSNK1G3 | 0.32404179 |
| 137 | IRAK2 | 0.32156358 |
| 138 | LYN | 0.31069672 |
| 139 | CDK1 | 0.31068650 |
| 140 | MAP3K4 | 0.29049767 |
| 141 | MAP3K8 | 0.29029400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.38543785 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.78845969 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 3.70896821 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.08351626 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.94359340 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.89135544 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.83735687 |
| 8 | Spliceosome_Homo sapiens_hsa03040 | 2.64273321 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.45122806 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.42683181 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.34318177 |
| 12 | RNA transport_Homo sapiens_hsa03013 | 2.17978494 |
| 13 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.15562147 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.13328184 |
| 15 | Homologous recombination_Homo sapiens_hsa03440 | 2.11470067 |
| 16 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.03531233 |
| 17 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.03209881 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.97261445 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.92636651 |
| 20 | Protein export_Homo sapiens_hsa03060 | 1.92038169 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.91985070 |
| 22 | Basal transcription factors_Homo sapiens_hsa03022 | 1.74419642 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.67513919 |
| 24 | Cell cycle_Homo sapiens_hsa04110 | 1.60056538 |
| 25 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.56225136 |
| 26 | Purine metabolism_Homo sapiens_hsa00230 | 1.53098020 |
| 27 | Alzheimers disease_Homo sapiens_hsa05010 | 1.51905523 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.41868768 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.37472755 |
| 30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.35673187 |
| 31 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.35254643 |
| 32 | RNA degradation_Homo sapiens_hsa03018 | 1.27338598 |
| 33 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.24300210 |
| 34 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.17625505 |
| 35 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.11004918 |
| 36 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.08993723 |
| 37 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.08896315 |
| 38 | Nicotine addiction_Homo sapiens_hsa05033 | 1.06838722 |
| 39 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.06139991 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.03907768 |
| 41 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.03712275 |
| 42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.03017779 |
| 43 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.02717818 |
| 44 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.00088828 |
| 45 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.96015347 |
| 46 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.93047060 |
| 47 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.90911039 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 0.90878919 |
| 49 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.89084412 |
| 50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.84139233 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.82977082 |
| 52 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.82298481 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82197705 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81895265 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 0.81576872 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81088653 |
| 57 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79503809 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.76175982 |
| 59 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.74830731 |
| 60 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.74697843 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72963006 |
| 62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71457677 |
| 63 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.70353956 |
| 64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69825350 |
| 65 | Long-term potentiation_Homo sapiens_hsa04720 | 0.65381031 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64991348 |
| 67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.64106861 |
| 68 | Alcoholism_Homo sapiens_hsa05034 | 0.63639394 |
| 69 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.63319932 |
| 70 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.62554187 |
| 71 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62083117 |
| 72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.61747254 |
| 73 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.60331281 |
| 74 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.58981961 |
| 75 | Olfactory transduction_Homo sapiens_hsa04740 | 0.57476280 |
| 76 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.54609264 |
| 77 | Legionellosis_Homo sapiens_hsa05134 | 0.51508413 |
| 78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.50629666 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47252288 |
| 80 | Shigellosis_Homo sapiens_hsa05131 | 0.47096708 |
| 81 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.47085514 |
| 82 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.46440758 |
| 83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.44215487 |
| 84 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.43297020 |
| 85 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42631516 |
| 86 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.42562712 |
| 87 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.42301174 |
| 88 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42220229 |
| 89 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.42008328 |
| 90 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.40098763 |
| 91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39869570 |
| 92 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37896114 |
| 93 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.36448587 |
| 94 | Thyroid cancer_Homo sapiens_hsa05216 | 0.35658571 |
| 95 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.33553444 |
| 96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33215737 |
| 97 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.32842444 |
| 98 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.32722161 |
| 99 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30654082 |
| 100 | Carbon metabolism_Homo sapiens_hsa01200 | 0.29355818 |
| 101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.28890941 |
| 102 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.28800870 |
| 103 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.27952803 |
| 104 | Morphine addiction_Homo sapiens_hsa05032 | 0.27870271 |
| 105 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.27058917 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26614310 |
| 107 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.26570186 |
| 108 | GABAergic synapse_Homo sapiens_hsa04727 | 0.26026762 |
| 109 | Phototransduction_Homo sapiens_hsa04744 | 0.20973201 |
| 110 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.20293360 |
| 111 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.20036367 |
| 112 | Asthma_Homo sapiens_hsa05310 | 0.19739000 |
| 113 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.19483338 |
| 114 | Apoptosis_Homo sapiens_hsa04210 | 0.17380395 |
| 115 | Circadian entrainment_Homo sapiens_hsa04713 | 0.17374344 |
| 116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.16688858 |
| 117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.16534869 |
| 118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.16068571 |
| 119 | Long-term depression_Homo sapiens_hsa04730 | 0.14313781 |
| 120 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.13324578 |
| 121 | Taste transduction_Homo sapiens_hsa04742 | 0.13164449 |
| 122 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.13101202 |
| 123 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.12943749 |
| 124 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.12929337 |
| 125 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.12907489 |
| 126 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.12898173 |
| 127 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.11631800 |
| 128 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.11601482 |
| 129 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.11175108 |
| 130 | Lysosome_Homo sapiens_hsa04142 | 0.08834497 |

